| DIANA-TarBase v7. 0: indexing more than half a million experimentally supported miRNA: mRNA interactions IS Vlachos, MD Paraskevopoulou, D Karagkouni, G Georgakilas, ... Nucleic acids research 43 (D1), D153-D159, 2015 | 820 | 2015 |
| Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment G Werba, D Weissinger, EA Kawaler, E Zhao, D Kalfakakou, S Dhara, ... Nature Communications 14 (1), 797, 2023 | 46 | 2023 |
| Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer F Fostira, E Saloustros, P Apostolou, A Vagena, D Kalfakakou, D Mauri, ... Breast Cancer Research and Treatment, 1-9, 2018 | 46 | 2018 |
| Functional characterization of CHEK2 variants in a Saccharomyces cerevisiae system A Delimitsou, F Fostira, D Kalfakakou, P Apostolou, I Konstantopoulou, ... Human Mutation, 2019 | 45 | 2019 |
| One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility gene F Fostira, I Kostantopoulou, P Apostolou, MS Papamentzelopoulou, ... Journal of Medical Genetics 57 (1), 53-61, 2020 | 34 | 2020 |
| Genetic analysis and clinical description of Greek patients with Peutz-Jeghers syndrome: Creation of a National Registry F Fostira, V Mollaki, G Lypas, G Alexandrakis, E Christianakis, M Tzouvala, ... Cancer genetics 220, 19-23, 2018 | 16 | 2018 |
| POLQ inhibition elicits an immune response in homologous recombination–deficient pancreatic adenocarcinoma via cGAS/STING signaling G Oh, A Wang, L Wang, J Li, G Werba, D Weissinger, E Zhao, S Dhara, ... The Journal of Clinical Investigation 133 (11), 2023 | 13 | 2023 |
| BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects P Apostolou, F Fostira, C Kouroussis, D Kalfakakou, A Delimitsou, ... International journal of cancer 147 (5), 1334-1342, 2020 | 10 | 2020 |
| Contribution of RAD51D germline mutations in breast and ovarian cancer in Greece I Konstanta, F Fostira, P Apostolou, E Stratikos, D Kalfakakou, ... Journal of human genetics 63 (11), 1149-1158, 2018 | 10 | 2018 |
| PALB2 c. 2257C> T truncating variant is a Greek founder and is associated with high breast cancer risk A Vagena, M Papamentzelopoulou, D Kalfakakou, P Kollia, ... Journal of human genetics 64 (8), 767-773, 2019 | 9 | 2019 |
| CHEK2 Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and … P Apostolou, V Dellatola, C Papadimitriou, D Kalfakakou, E Fountzilas, ... Cancers 13 (9), 2106, 2021 | 8 | 2021 |
| MARGINAL: An Automatic Classification of Variants in BRCA1 and BRCA2 Genes Using a Machine Learning Model V Karalidou, D Kalfakakou, A Papathanasiou, F Fostira, GK Matsopoulos Biomolecules 12 (11), 1552, 2022 | 3 | 2022 |
| CanVaS: Documenting the genetic variation spectrum of Greek cancer patients D Kalfakakou, F Fostira, A Papathanasiou, P Apostolou, V Dellatola, ... Human mutation 42 (9), 1081-1093, 2021 | 2 | 2021 |
| Pitfalls in variant annotation for hereditary cancer diagnostics: The example of Illumina® VariantStudio® D Kalfakakou, I Konstantopoulou, D Yannoukakos, F Fostira Genomics 113 (1), 748-754, 2021 | 1 | 2021 |
| Abstract B021: Clonal heterogeneity in human pancreatic adenocarcinoma and its contribution to therapeutic resistance D Kalfakakou, EA Kawaler, D Tamayo, L Wang, R Hernandez, ... Cancer Research 84 (2_Supplement), B021-B021, 2024 | | 2024 |
| Breast cancer in very young (≤ 35 years) women: clinicopathological and genetic features of the disease from a breast surgical oncology department D Nasikas, D Kalfakakou, F Fostira, C Iosifidou, A Fokianou, P Ntasiou, ... European Journal of Surgical Oncology 49 (2), e91-e92, 2023 | | 2023 |
| Author Correction: Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment G Werba, D Weissinger, EA Kawaler, E Zhao, D Kalfakakou, S Dhara, ... nature communications 14, 2023 | | 2023 |
| Polymerase theta inhibition activates the cGAS-STING signaling pathway and elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma. G Oh, A Wang, L Wang, J Li, G Werba, D Weissinger, E Zhao, S Dhara, ... CANCER RESEARCH 82 (22), 102-102, 2022 | | 2022 |
| Abstract B065: Polymerase theta inhibition activates the cGAS-STING signaling pathway and elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma G Oh, A Wang, L Wang, J Li, G Werba, D Weissinger, E Zhao, S Dhara, ... Cancer Research 82 (22_Supplement), B065-B065, 2022 | | 2022 |
| Abstract PR010: Single-cell sequencing elucidates the effects of chemotherapy on cancer cell heterogeneity and the tumor microenvironment of human pancreatic adenocarcinoma D Weissinger, EA Kawaler, G Werba, E Zhao, D Kalfakakou, S Dhara, ... Cancer Research 82 (22_Supplement), PR010-PR010, 2022 | | 2022 |
Florentia FostiraResearcher, NCSR DemokritosVerified email at rrp.demokritos.gr
